IntraGel Therapeutics
Cancer Drug Delivery Platform
Active
Seed
Startup
Nazareth
Founded 2020-12
INTRAGEL is a research-driven company dedicated to pioneering an advanced treatment for solid tumors using our state-of-the-art gel-based drug delivery technology. The SRGel platform enables local and prolonged release of a wide range of anti-cancer medications offering new life-changing cancer treatment options. The SRGel platform is revolutionizing cancer…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$450K
Employees6
Founded2020-12
HQNazareth
Patents1
Confidence90
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technology
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals